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1-1 Purpose of this Report
The first section of the report of this study, "An Overview and
Synthesis of City Reports", describes and compares the drug situation
in the seven cities. This section aims to do the following;
(1) Examine the benefits, the drawbacks and the comparability of
indicators that are used to assess and monitor drug aisuse. The
data to which these issues refer are provided in the appendix.
(2) Discuss the extent to which it is possible to develop a more
integrated * framework of communication' that would allow for
improved and more comparable assessment within Europe;
(3) Make recommendations as to how monitoring of drug aisuse might
be improved in the future.
1.2 Assessment, monitoring and indicators of drug misuse
Assessment
This term is used to mean any relatively systematic exercise to
ascertain the situation regarding drug aisuse in a community at a 
particular point in time. An assessment thus presents a static 'window'
on the situation. Many of the ad hoc surveys and other special research
studies summarised in the first volume provide examples of information
that has contributed to the construction of this sort of picture. The
disadvantages of such assessments are that (a) they rapidly become out
of date, and (b) they fail to provide the regular feedback that is
needed to monitor changes, evaluate the relative impact of various
interventions and compare trends in different communities.
Monitoring
This is taken to mean the systematic and continuing collection,
collation and interpretation of information at regular intervals. It
differs from assessment in that it is concerned with changes over time
and thus provides a more dynamic picture of events. This dimension is
vital if epidemiological information is to contribute to the evaluation
and planning of cost-effective policies and services. Monitoring




Soaie studies have attempted to obtain a direct and comprehensive count
of all cases in a given category. One example is provided by intensive
case-finding studies, such as have been carried out in Sweden and
Dublin, which actively seek to identify all heavy drug misusers in a 
community over a 6 or 12 month period. Such methods, however, are
expensive, time consuming, difficult to apply on a wide scale, and
limited both by the need for confidentiality and by the fact that much
drug misuse is illegal and stigmatised. As a result, it is more
convenient to concentrate on collecting aore accessible information
about events which are known, or assumed, to bear a relationship to
the pattern and level of drug misuse in the community. Such partial
measures are called indicators.
Apart from case-finding studies, the broad categories of indicator
methods are as follows.
(1) Use of available statistics as indicators (e.g. drug-related
deaths, seizures, arrests, treatment demand, hospital
admissions, hepatitis cases, illicit drug price).
(2) Surveys, record reviews or reporting systems o£ drug misusers
seen in selected agencies (treatment centres, prisons etc.).
(3) Ethnographic studies of drug misusers in the community.
(4) Surveys of the general population, school/student population,
or military conscripts.
(5) Statistical projections on the basis of information obtained
through combinations of the methods listed above*
Some of these indicators are considered in more detail'in Chapter 2.
The prospects for developing a more integrated framework are discussed
in Chapter 3.
Approach taken in the roulti-city study
•i
Throughout this study, the main focus has been on more harmful,
problematic drug taking rather than on the wider pattern of all drug
taking in the general population. This has been taken to mean regular
use of narcotics, intravenous use, and heavy multiple drug use. Thus
most attention is . devoted to indicators that reflect the medical,
social, and legal consequences of drug misuse. The experts involved in
the multi-city study consider that it is important to improve the
quality of these indicators because (a) they relate to those aspects of
drug misuse that are most acutely felt and for which effective
responses are most urgently required, and (b) they are already being
used by many countries as a basis for deciding whether, and in what
ways, interventions are needed. This approach is complemented by school
and population surveys that aim to provide a broader picture of drug
use in the community. In addition, ethnographic studies can provide




The indicators covered in this report are considered to have an
association with drug misuse, but the exact nature of that association
is often unknown. Furthermore, any single indicator reflects only one,
possibly atypical, facet of the whole picture. It is therefore
essential to (a) use several indicators that draw on a range of
different sources of information; (b) take account of extraneous
factors that may distort the data.
Factors which influence the indicators include cultural attitudes and
policies regarding drug misuse in the cities concerned, the type and
availability of facilities, the priorities and level of activity of the
bodies from whom the  data are derived, the definitions and recording
practices that they use, and the mechanisms through which data from
individual agencies are aggregated prior to being made available.
It is therefore essential to supplement bare statistical data with an
understanding both of the context in which they were collected and of
the process by which the statistics were generated.
1.3 What does 'Comparability' Mean?
Comparability is central to this study. Thus it is important to define
what it means.
Comparability of definitions
Any epidemiological study requires clear and consistent criteria. In
particular, this includes definition of: (a) who or what is counted as
a 'case' or 'event' ('addict','drug-related death* etc.); (b) the area
and population base to whom the data refer (e.g. per 1,000 population
aged 15-39, and whether nonresidents are included); and (c) the period
of time involved.
In Chapter 2 these criteria are applied to each indicator. In general,
the degree of comparability varies considerably, but is not high if one
considers exact comparability. However in a somewhat larger number of
cases, there is sufficient similarity to allow rough comparisons to be
drawn, at least between some cities.
Comparability of the significance of the data
Whilst comparability of criteria is important, it is not, in itself,
sufficient to achieve the objective of the excercise, which is to
establish greater comparability of the data in terms of what they
signify regarding the relative situations in the cities. Even given
identical definitions, it would still be necessary to interpret the
data in the light of the cultures, policies, institutions etc. of the
cities concerned. It was to convey this broader sense of comparability
that the term 'framework of communication' was coined. Chapter 3 
suggests what this could mean in practice.
What is to be compared?
The question of which aspects of the situation in the cities are to be
compared is partly determined by practical constraints. At the same
time, it is important regarding the sort of data that should be
collected in the future. The levels at which the question of comparison
might be approached are considered in 3.2. Possibilities include:
descriptive comparison (see section 1 of this report)
the prevalence of drug misuse
the rates of change in drug misuse
the characteristics of drug misusers
the patterns of agency contact
the importance and costs of drug-related problems
the causes of drug misuse
- the impact of interventions.
1.4 Criteria for evaluating indicators
Members of the multi-city working group agreed that the indicators
should be evaluated according to the following criteria.
1. Comparability of definitions and terms
This includes whether clear definitions exist, whether they are
consistently applied and the extent to which they are comparable.
2. Availability, accessibility and rapidity
This refers to whether the data are collected at all, and how easily,
how quickly and how frequently the data become available.
3. Reliability
This refers to whether the data can be taken as an accurate record of
the events which they are supposed to record.
4. Validity
This refers to the degree to which an indicator actually reflects
changes in drug misuse rather than other, extraneous factors.
5. Relevance
This refers to the ways in which an indicator can, or cannot, be useful
for assessing and monitoring drug misuse (for example, in terms of the
categories listed in 1.3 above).
Through applying these criteria, it is possible to comment on the
benefits and drawbacks of the indicators, and on the level at which
comparison can occur. This in turn highlights areas where practical
efforts towards improvements should be directed. This is the concern of
the next chapter.
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2. CRITICAL REVIEW OF THE INDIVIDUAL INDICATORS
This chapter assesses each indicator according to criteria in 1.4
2.1 First treatment demand
Treatment demand refers to people who are seen by treatment centres,
therapeutic communities, general practitioners, etc. and who are
requesting treatment for their drug misuse (usually drug dependence).
Hospital admissions are considered separately in the next section. Of
particular interest is First Treatment Demand - requests for treatment
by people who have not been treated before. This is believed to provide
a sensitive indicator of changes in the pattern of serious drug misuse.
1. Comparability of definitions
There is little exact comparability. Further, there ;are large
differences between treatment systems, so the data have different
significance in different cities. First treatment demand refers to:
Amsterdam: Addicts registered for the first time (ever) by the
Central Registration System (CMR) following provision of
methadone at any of a wide range of facilities (public
health service, GPs, clinics, hospital, prisons and police
stations)
Dublin: Drug abusers taken on for treatment for the first time
(ever) by Jervis Street, the city's primary treatment
centre (largely outpatient, includes methadone). GPs,
prisons and hospitals are not included.
Hamburg: Drug addicts, who did not attend in the previous
requesting aid from drug counselling centres.
year.
London: Narcotic addicts notified for the first time (ever) to the
Home Office by treatment centres, hospitals, GFs and
prison medical officers.
Paris: New cases seen by individual treatment centres (no 
consistent criteria). (Data are collated from health
institutions on addicts seen in the last quarter of each
year, but they do not distinguish new cases.)
Rome First applications (ever) for treatment by addicts to
public health facilities (outpatient methadone and
counselling centres and therapeutic communities).
Stockholm: Drug misusers treated by therapeutic communities and other
social and medical facilities ' (residential and
nonresidential). The data do not distinguish new cases.
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In all cities apart from Stockholm, treatment demand data refer mainly
to opiate addicts. However, only in Dublin are cases actually specified
in terms of ICD 9 codes, though in London, Paris and Stockholm, data
are reported using similar categories such as 'primary drug of
addiction*, and in Amsterdam and Rome, the nature of the treatment
services implies that most clients are opiate addicts. In Amsterdam
and London, and to a lesser extent in Dublin and Rome, the monitoring
systems are also primarily aimed at opiate addicts and are thus likely
to be relatively insensitive to the misuse of other drugs. In Hamburg,
there are no data on the main drugs involved, and in Paris and
Stockholm, they are not available separately for the first demand.
In Hamburg and Rome, first treatment demand refers to first requests
for treatment, in Amsterdam and Dublin it refers to the number taken on for
treatment, and in London and Paris to an uncertain mixture of both.
The distinction is important, since the numbers actually taken on for
treatment may reflect the capacity of services, whereas the numbers
requesting help are more likely to reflect the demand for treatment.
In the cities where data are provided (Appendix, Table II) they refer
to first demands over a given year (12 month treatment incidence). The,
only cities which provide data as a rate per 1,000 population aged 15-
39 are Amsterdam, Dublin, London and Rome. In addition, data for the
number in treatment and demanding treatment in any given month (point
treatment prevalence and incidence) are available in Amsterdam and Rome
(and, for the end of the year only, in London). The value of this
additional data is that it is possible to monitor the turnover of
clients using treatment services. Only Amsterdam and Dublin record data
on residence.
In Amsterdam, Dublin, London and Rome, the data refer to unique
individuals. In Hamburg, there may be some double-counting. In Paris
there appears to be inconsistency between institutions in terms of
whether they record the number of individuals or the number of demands.
2. Availability, accessibility and rapidity
Basic data on first treatment are centrally collated, routinely
available, and easily accessible in Amsterdam, London, and Rome. They
are readily available in Dublin, though they have to be obtained from
the treatment agencies. In Stockholm, there are no data on first
treatment demand, though general treatment data are available from
selected agencies. In these five cities, other data given include' main
drug, age and sex. In Paris, the only data available on first demand
came from a special survey in 1981 and 1982. In Hamburg, information-
available from drug counselling services is limited to a rough figure
for 'new clients'.
The data are available rapidly (updated each month) in Amsterdam and
Rome, and fairly rapidly (within one year) in Dublin, Hamburg, London
and Stockholm. In Paris,, data from reports by institutions in the last
quarter of each year are available three years later.
The data from all cities, except Stockholm and. Hamburg (though the
information is very limited) are obtained largely from medical
agencies. Hamburg and Rome include data on therapeutic communities,
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though these are second line facilities to which addicts are referred
on. Whilst all cities collect data from treatment centres, only
Amsterdam and London include data from GPs.
Thus, apart from Stockholm and Hamburg, there is a marked absence of
data concerning demand for treatment or help from nonmedical agencies.
It is clear from the city reports that such services exist in most
cities, often on a voluntary (nonstatutory) or private basis. It is
important that efforts are directed towards obtaining data from such
agencies. Thus in cities where treatment centres concentrate on opiate
addicts (eg by providing methadone), patterns of drug misuse which do
not involve dependence on opiates may be missed.
It can be particularly useful to obtain data from community-based,
first-line agencies, medical or nonmedical. By definition, they are
closer and more sensitive to changes in the pattern of drug misuse.
3. Reliability
The reliability of the data varies. In general, data derived from
treatment centres are relatively reliable measures of the demand on the
services covered. For nonspecialist agencies, the data are more likely
to be unreliable.
4. Validity
First treatment demand has different validity in different cities. It
is considered a valid indicator of trends in drug misuse in Dublin and
London, and in the special surveys conducted in Paris. In Amsterdam and
Rome, the existing data tend to reflect the expansion of the monitoring
systems. Once they have stabilised, it is thought that they will
generate valid measures. In Hamburg and Stockholm, first treatment
demand is considered to reflect the availability of services rather
than trends in drug misuse.
Conclusions
The data on first treatment demand provided in the Appendix (Table II)
are considered to be a useful indicator of trends in drug misuse in
most of the cities. However, it is affected by the type and availability
of services and by which services are monitored. Furthermore, it is a 
'lagged' indicator, since there is an interval of up to several years
between initial drug use and seeking help. Data on this latency period
have been found to be of epidemiological value in Dublin, London and
Paris. Elsewhere (United States, Berlin) they have been used to generate
prevalence estimates. They can also provide information about the point
in their drug careers at which drug misusers seek treatment. Other
examples of the use of treatment data include the study of how long
addicts remain in treatment or utilise several agencies (Amsterdam). 
Despite differences, there are similarities between some of the cities.
Thus Amsterdam, Dublin, London and Rome all have facilities which
include methadone treatment and all report data on first treatment
demand by opiate addicts from those facilities. These data fulfil
enough of the above requirements to permit a crude degree of
preliminary comparison.
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(a) Routine data gathering should be centralised in one database
(respecting the requirements of confidentiality).
(b) As broad a range of first-line services as is practical should
be covered, including GPs and nonmedical agencies,
(c) It is important to develop, or to maintain, data gathering
structures that clearly distinguish new cases as a separate
category in the overall treatment data.
(d) Ideally, it is preferable to record the number of requests for
treatment because the number entering treatment is liable to
reflect the capacity of the service.
(e) Data should be recorded using consistent criteria for primary
diagnosis (ICD 9), including main drug type, route of
administration, age, sex and whether resident of city or not.
Ideally, the age of first drug use should also be recorded,
since this provides data on the 'latency' period.
2.2 Hospital admissions
This indicator can be considered a subcategory of treatment demand in
that it refers mainly to inpatient treatment of drug dependence.
However, it also includes hospitalisation for other drug-related
conditions (drug psychoses, nondependent drug abuse). If secondary
diagnoses are available, then it can also indicate the range of other
medical conditions for which addicts enter hospital (infections,
hepatitis etc.).
1. Comparability of definitions
All cities use the term 'hospital admission' in the sense of the WHO
definition: "a stay in hospital lasting one night or more, irrespective
of whether the patient is admitted for the first time, re-admitted...or
transferred from another hospital." However, there are differences in
how the data are collected and reported which make it impossible to
compare all cities. In some cities, there are more than one source of
data.
Amsterdam: Primary and secondary discharge diagnoses from general
hospitals; primary admission diagnoses from psychiatric
hospitals; addicts registered by the CMR following a 
request for guidance whilst in hospital.
Dublin: Primary and secondary discharge diagnoses from general
hospitals; primary and secondary admission diagnoses from
psychiatric hospitals.
Hamburg: Addicts admitted to the city's detoxification unit.
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London: Primary and secondary discharge diagnoses froa general
hospitals; primary and secondary admission diagnoses from
psychiatric hospitals.
Paris: Addicts reported in a survey of institutions during the
last quarter of each year.
Rome: Addicts admitted to hospital for emergencies (no clear
criteria).
Stockholm: Discharge diagnoses from psychiatric hospitals; drug
misusers admitted to selected hospital-based drug
treatment units.
Amsterdam, Dublin, London and Stockholm use ICD 9 in routine hospital
statistics. The relevant codes are drug psychosis (292), drug
dependence (304) and nondependent abuse (305.2-.9). Other cities do not
report any hospital statistics based on ICD 9. However, in Paris, and
in selected Stockholm treatment centres, the data are classified by
primary drug in a way that is similar to ICD 9. The data from Hamburg
and from the Amsterdam CMR system refer primarily to opiate addicts. In
Rome, hospital admissions refer mainly to addicts treated for
emergencies, but no special criteria are provided for addicts.
In Amsterdam, Dublin, Hamburg and London, hospital admissions are expres
as a rate per 1,000 population. On the basis of existing information,
it would not be possible to rate the data from the other cities.
In Dublin and London, data refer to primary and secondary diagnoses for
both general and psychiatric hospitals. In Amsterdam, psychiatric data
refer to primary diagnoses only.
In most cases, the data refer to the number of admissions or
discharges, not to the number of individuals involved. The exception is
the Amsterdam CMR data. In Stockholm, the number of admissions each
year is approximately double the number of persons involved. In London,
few individuals are admitted more than once in a year. In other
cities, the degree of double-counting is unknown.
2. Availability, accessibility and rapidity
Data are available in all cities, but to a varying degree. Thus only in
Amsterdam, Dublin, and London are routine data available from both
general and psychiatric hospitals. In Stockholm routine data are
available for psychiatric hospitals only, In Hamburg information is
available on addicts admitted to the special detoxification unit only.
In Paris, data are available from a survey of cases seen by institutions
in the last quarter of each year. In Rome, only a few data can be
obtained, compared to those available from public (special) facilities.
With the possible exception of Dublin, data are not directly or easily
accessible in the relevant form. It is usually necessary to request the
relevant authorities to make a special analysis to extract the data. In
London and Stockholm, for example, this involves separating city data
from larger areas (and in the case of London, also aggregating them
from four separate regions).
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With the exception of two London regions, routine hospital data are not
available within 12 months. In Amsterdam, Dublin, and other London
regions, data for 1984 were not available until the middle of 1986. In
Stockholm and Paris (last quarter survey), the delay is several years.
This is too long for the information to be useful.
Data from special hospital-based drug treatment units are available
more easily and rapidly. Thus in Hamburg and Stockholm, data for 1985
were available in the first half of 1986.
3. Reliability
This is unknown. The reliability of hospital diagnostic data in general
is not high on account of errors both in diagnosis and in coding and
reporting procedures. It is reasonable that data on drug misuse should
be viewed cautiously as a measure of the numbers and diagnoses of drug
misusers admitted to hospital.
4. Validity
On their own, hospital admissions are limited as an indicator of the
pattern of drug use in a city. They represent an unknown, usually small
fraction of all misusers. Changes in the number and characteristics of
patients admitted are influenced by the wider situation, but they are
also determined by the availability of beds, the availability of other
resources for diagnosis and treatment, by public attitudes to
hospitalisation, and by the use made of hospital by other medical or
social welfare agencies.
It is likely that the validity of this indicator varies between cities.
It appears that existing data on hospital admissions may have some
validity as an indicator of broad trends in Amsterdam, London and
Stockholm. It seems that, compared to general hospitals, psychiatric
admissions are more dependent on the attitudes of both professionals
and addicts towards hospitalisation.
Conclusions
The data can only be used and compared in the light of the referral and
admission policies and health care delivery systems in each city.
Furthermore, the reliability o£ the data, especially from routine
hospital statistics, is questionable. However, whilst there are
limitations, the data could, if better collected, be useful for: (a)
monitoring the use made by drug users of inpatient facilities compared
to other treatment facilities; (b) estimating the cost to health care
systems of drug misuse, and (c) comparing the role of inpatient
treatment between cities.
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(a) The usefulness of the data would be improved through more
direct, rapid and routine channels for aggregating the data.
(b) Data from both general and psychiatric hospitals should be
collected and reported separately.
(c) Data on secondary diagnoses involving drug dependence would
give a fuller picture of the total number of addicts
hospitalised and the range of reasons for their admission.
(d) ICD 9 criteria should be employed.
(e) Special studies of hospital admissions are necessary to help to
improve the reliability of the data. ,-
2.3 Viral hepatitis
Hepatitis is sometimes used as an indicator of the incidence of
intravenous drug use, because sharing of syringes is an important way
in which the disease is transmitted. It is of no significance regarding
other methods of drug taking (smoking, sniffing etc.). However it is
only hepatitis types B and nonAr-nonB which are relevant. The more
common hepatitis type A is not specifically related to drug misuse.
Moreover, the role of other important risk factors, such as homosexual
contact, must be taken into account.
1. Comparability of definitions
In theory, case definitions should be comparable, since there are
established chemico-clinical diagnostics procedures. In practice the
data are not comparable.
Amsterdam: Cases of hepatitis B notified to the public health
authorities by general practitioners, by source of
infection.
Dublin: Positive tests for hepatitis B amongst addicts admitted to
hospital, or seen at the Jervis Street Centre.
Hamburg: Hepatitis cases reported by doctors to the city health
authority, by type but not by source of infection.
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London Hospital inpatient discharge diagnoses of hepatitis B (ICD
9) but not by source of infection; positive tests for
hepatitis B reported to the central public health
laboratory by local laboratories, by source of infection;
notifications of hepatitis to local public" health




Positive tests for hepatitis in patients admitted to
hospital for infectious diseases, by type and source of
infection; notifications of hepatitis to the public
health authorities, but not by type or source of
infection; voluntary reports of hepatitis to Institute of
Health, by type but not source of infection.
Stockholm: Hepatitis B and NonA-nonB notified to the public health
authorities, by type but not by source of infection.
Apart from Paris, all cities report data that distinguish hepatitis B 
(and sometimes nonA-nonB). Of these six cities, all but Dublin report
data on notifications to the public health authorities, but only
Amsterdam and London include information on whether cases are drug-
related. Dublin and Rome report data based on serological tests on
hospitalised addicts.
2. Availability, accessibility and rapidity
Data are available in all cities except Paris. However, routine data
are very basic and often incomplete. They are easily accessible in
Amsterdam, Dublin, Hamburg and Stockholm, and relatively accessible in
London and Rome. Data are available rapidly in Dublin, Hamburg, London
(notifications) and Rome (voluntary reporting to Institute of Health).
3. Reliability
The data from notifications of hepatitis B to public health facilities
cannot be considered a reliable measure of drug-related hepatitis in
the cities, since (a) the degree of under-reporting is unknown, and (b)
information on the source of infection is not recorded in most cities.
Even in Amsterdam and London, where drug misuse is distinguished from
other risk factors, much information is missing.
Data from serological screening in Dublin and Rome are reliable
measures of hepatitis B amongst hospitalised addicts. Additionally, in
Rome, they are reliable measures of the proportion of addicts aracngst
patients hospitalised for hepatitis.
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4. Validity
In most cities, it is not clear whether the incidence of hepatitis B 
(and nonA-nonB) can be used as a valid indicator of the incidence of
intravenous drug use. In the cities where notifications to public
health facilities do not distinguish drug-taking from other risk
factors (Hamburg, Rome and Stockholm) it cannot be assumed that
variations in hepatitis B reflect changes in drug use. However in
Hamburg and Stockholm, there is a correlation between this and other
indicators, suggesting that it may be a valid indicator. In the cities
where notifications to public health facilities do distinguish drug-
related cases (Amsterdam and London) the unreliability of the data
makes it hard to draw conclusions, although in London, there is some
correlation with other indicators.
In Dublin, serological screening of hospitalised addicts is considered
to be a valid indicator that pointed to an increase in drug misuse
earlier than other indicators. In Rome, the data points to an
increasing number and proportion of addicts amongst patients
hospitalised for hepatitis over the period when intravenous drug use
was increasing.
Conclusions
Hepatitis data may potentially be a useful indicator of drug use by
injection. However, in most cities the quality of the data must be
improved before its epidemiological value can be properly assessed. The
information is in any case useful for improving health care and health
education for people already known to be at risk, and for evaluating
efforts to reduce the incidence of hepatitis.
Recommendations
(a) Routine notification of hepatitis to public health facilities
should specify both the type of hepatitis and the likely source
of infection.
(b) The extent to which doctors report cases, and the accuracy of
the information, should be checked from time to time.
(c) Serological screening of hospitalised addicts, and possibly of
other treatment and institutional groups, should be routine.
(d) Data on risk factors should be systematically recorded for
patients treated for hepatitis.
(e) Data (anonymous) should be routinely available to the agency
responsible for collating information on drug misuse.
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2.4 Drug-related deaths
This is an important indicator, both because it concerns dramatic and
serious events, and because the number of deaths is often taken as an
indicator of the true situation.
1. Comparability of definitions
Amsterdam: Unnatural deaths of drug " takers by overdose; deaths
indirectly caused by drug misuse (drug-related diseases,
homicides, accidents).
Dublin: Deaths of drug users known to the police or to Jervis
Street treatment centre.
Hamburg: Deaths by overdose of narcotic drugs (accidental or
suicide), deaths of chronic drug takers by overdose of
other drugs, and deaths indirectly caused by drug misuse
(suicides by other means and accidents under the influence
of illicit drugs, and deaths from drug use related
diseases).
London: Deaths by poisoning (ICD 9); deaths of addicts identified
through search of Coroners' records.
Paris: Deaths by overdose of illicit drugs recorded by the police
and subsequently confirmed by medical diagnosis.
Rome: Deaths by overdose of narcotics, deaths in circumstances
indicative of drug addiction, irrespective of whether or
not the persons are known to be addicts.
Stockholm Deaths due to drug addiction (ICD 9)
Deaths in which drug addiction is diagnosed as the underlying cause on
the basis of ICD 9 codes are not considered satisfactory in any of the
cities. This is because of uncertainties over the basis on which the
death certificates are completed and evidence that they indicate only a 
minority of drug-related deaths.
Deaths of addicts known to the police are not adequate since the
criteria for such data are likely to vary and deaths indirectly arising
from drug use are likely to be missed.
Deaths of addicts who have been registered or notified by treatment
systems omit drug takers who have not been in contact with the
treatment system and include deaths that may have occurred for reasons
unrelated to drug use.
Deaths by overdose exclude drug-related deaths that occur for other
reasons and include suicides by individuals who are not otherwise 'drug
misusers'. In any case, an overdose is not a clearly defined event.
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2. Avai labi l i ty , access ib i l i ty , rapidity
Data are available in all cities and are presented in the Appendix
{Table V). Where there are arrangements for reporting certain
categories of drug-related deaths separately from routine mortality
statistics, then the data are easily and rapidly accessible. Examples
are Amsterdam, Dublin, Hamburg, Rome and, for a limited category of
deaths, Paris.
3. Reliability
The reliability of the data varies, and is affected by (a) the extent
to which all unnatural or suspicious deaths are investigated (in terms
of medical, toxicological, circumstantial and other evidence regarding
the known drug-using status of the deceased) and (b) whether drug-
related deaths are specially recorded using explicit criteria.
Thus in Amsterdam, data on overdoses are considered reliable, but not
data on deaths indirectly related to drug-taking. In Dublin, data on
deaths of addicts known to the police or to Jervis Street are reliable,
but are likely to miss other drug-related deaths. In London, Paris and
Stockholm, the data are unreliable, apart from those produced by
special searches of death records. The most reliable system for
identification appears to that used in Hamburg, where any death in
which drugs are suspected or the cause of (youthful) death is unclear
is referred for a bio-chemical investigation of hair roots, which can
demonstrate recent morphine intake. The results are considered along
with other information before a drug-related death is recorded.
4. Validity
Even if data on drug-related deaths were reliable, it would still be
difficult to draw a direct relationship between the number of deaths
and the prevalence of drug misuse or addiction. Whilst large changes in
the number and characteristics of drug-related deaths probably indicate
a real change in the situation, it is necessary to examine a range of
other factors that might be involved. Thus the death rate may be
affected by variations in the potency of the drug, the nature of the
adulterants, the characteristics of the drug users, and whether the
drugs are injected or not.
Conclusions
No single criterion is adequate for defining a drug-related death. Data
on deaths are not comparable between all cities, though there are
similarities between some. The expert group are unanimous in urging
caution regarding significance of crude death statistics as an
indicator of the prevalence of drug misuse, especially in terras of
international comparison. The reasons lie in problems of definition, in
differences in how data are recorded, and in the fact that death rates
are affected by factors other than the prevalence of drug misuse. Some
of -the group consider that it is possible to take other factors into
account and to use death rates, in conjunction with other indicators,
to assess and monitor patterns of drug misuse. This is an area which
requires further exploration and, above all, better data-
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Recommendations
(a) It is necessary to distinguish between direct and indirect
drug-related deaths. The following criteria are put forward for
further discusion.
deaths arising directly from poisoning by illicit drugs
(overdose), whether accidental or suicidal;
deaths from poisoning with other drugs, if these were used
by a drug misuser as a substitute to bridge a supply gap?
suicides (by other means) which are a consequence of
having taken illicit drugs when other information
indicates that the person,is an active user;
accidents that result from the effects of illicit drugs;
deaths from illnesses resulting from drug misuse (eg
infections, hepatitis, AIDS); 
drug-related homicides.
(b) In all cases, the classification of a drug-related death should
be supported by objective evidence - toxicological, clinical
and circumstantial.
(c) Data on drug-related deaths should be routinely collated
through a single centre using the above criteria.
2.5 Police arrests
Police arrests are often used as a direct indicator of trends in
illicit drug misuse. However, they also reflect police activity.
1. Comparability of definitions
Two types of data are reported. The first refer to arrests for offences
against the drug laws. The second refer to addicts identified through
arrest, regardless of the offence.
Offences against the drug laws
Amsterdam: Number of persons arrested by police (first stage of the
procedure for bringing charges for specific offences).
Only a minority are subsequently charged.
Dublin: Number of persons charged for a specific offence. Excludes
persons arrested but not charged.
Hamburg: Number of detected cases of violations against the drug
laws; number of persons suspected of specific offences
against the drug laws.
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London: Number of arrests by the police (first stage of the
procedure for bringing charges for specific offences).
Most are subsequently charged.
Paris: Number of police arrests for offences involving
(data available for other illegal drugs).
heroin
Rome Number of persons charged with drug traffficking; number
of people mentioned for possession of small quantity.
Stockholm: Number of reported crimes against the drug laws; number of
persons suspected of crimes against the drug laws.
Whilst all cities report data on offences against the drug laws, they
do not all refer to the same point in the legal process. Thus Hamburg
and Stockholm both report the number of detected violations of the drug
laws and the number of persons suspected, regardless of whether this is
followed by formal arrest and subsequently criminal charges. In
Amsterdam, London and Paris, the data refer to arrests, and in Dublin
and Rome to the number of people charged. This can make a considerable
difference to attempts to compare cities. For example, in Amsterdam in
1985, only 20 percent of those arrested were charged, whereas in
London, most drug arrests are followed by a formal charge.
A further difficulty is that some cities report only the number of
persons (Amsterdam, Dublin and Rome) and others only the number of
events (London, Paris). Only Hamburg and Stockholm report both. In
Hamburg the number of suspected persons and the number of known
violations are about equal. In Stockholm, there are two known
violations per person. The number of people arrested may be a better
indicator, since increased police activity is more likely to affect
drug misusers who are already known to the police.
All cities except Stockholm report data on the drugs involved, though
Paris gives heroin arrests only. Data distinguishing possession from
trafficking are presented only for Hamburg and Rome, though in Rome,
the 'small amount' provision probably results in an underestimate of
the number of people found in possession by the police. However, data
on offence type are available in Dublin and London.
Arrested addicts
Only three cities report data on addicts who are arrested. In
Amsterdam, this is done by the police on the basis of uncertain
criteria. Data are also provided on arrested addicts provided with
medical assistance. In Hamburg and Stockholm, the data are based on
evidence of injection marks and additionally, in Hamburg, on the
statement of the arrested person. It appears unlikely that similar data
could currently be provided for the other cities.
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2. Availability, accessibility and rapidity
Data on arrests for drug offences are available in all cities. Although
they are easily and rapidly accessible to the police, they are not
always readily available for epidemiological purposes. Data on addicts
who are arrested are readily and rapidly available in those cities
where the data are collected, since there are established systems for
monitoring them.
3. Reliability
The reliability of the data as a measure of the number of known
violations, arrests, or charges for drug offences is not certain. In
principle, they should be reliable, though that is not thought to be so
in Rome, and changes in reporting procedures in Paris confuse the
picture. (In Paris, data on heroin arrests are more reliable than for
other drugs.) Only special studies of reliability will clarify this.
The reliability of data on arrested addicts depends on the process for
identifying addicts. In Amsterdam, it is the police who decide whether
to list someone as an addict. Unreliability is likely to arise from
mistaken classification by the police of 'drug users' as 'addicts', and
from failure to identify those who are addicted. The use of injection
marks as a criteria (Hamburg and Stockholm) should be reliable but only
for injecting addicts, though in Hamburg, statements regarding opiate
use made by arrestees are also taken into account.
4. Validity
The validity of arrests as an indicator of trends in drug misuse is not
clearly established in all cities, but is thought to vary between
cities. They are considered a valid indicator of trends in drug misuse
in Hamburg and, more cautiously, in Dublin and London. In Amsterdam
they show a parallel with other information. In Paris and Stockholm,
they are thought to reflect police activity as much as trends in drug
misuse, though in Paris, the trend for heroin reflects other
indicators. It is suggested there that arrests could be a useful
indicator if information were available on people arrested for the
first time. The effect of changes in police resources and priorities is
discussed further in the section on seizures. It is also suggested that
middle-class drug users are under-represented by this indicator.
Conclusions
Police arrests can be a useful indicator, but only if police practices
and priorities are taken into account. Furthermore, arrest data reflect
the differential vulnerability of various classes of drug users to
arrest. However, they are more direct measures than later stages in the
judicial process which, in addition, reflect prosecution and sentencing
policies. In general, it is likely that large changes in the number of
arrests and the profile of drugs involved do indeed reflect real
changes, especially if there are no obvious changes in policy. There is
some comparability between some cities, but further work is needed
before firm conclusions can be drawn. Despite the above difficulties,
this is an important indicator because it complements treatment
indicators. It must be interpreted in the context of other information.
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Recommendations
(a) Comparability would be improved if the data referred to
similar points in the judicial process. At present, arrests are
reported by the largest number of cities.
(b) Data should be available on the number of known violations that
result in arrest, and on the number of arrests that result in a 
charge. This would assist in comparing the significance of the
data.
(c) Both the number of arrests and the number of people should be
recorded.
(d) Data should be recorded per drug and offence type, and, if
possible, by sex and age.
(e) Data on persons arrested for drugs for the first time should be
reported separately.
(f) Information on police resources devoted to drug enforcement
should be available (eg number of police on drugs work).
2.6 Imprisonment
Imprisonment has not been widely used as an indicator of the extent of
drug misuse. It was included in order to examine whether it could
provide useful data.
1. Comparability of definitions
There are two types of data that are reported. The first refers to
court sentences of imprisonment for offences against the drug laws
(which may involve people who are not drug users). The second refers to
the number of addicts in prison (who may have been sentenced for other
offences).
Imprisonment for offences against the drug laws.
Imprisonment itself is comparably defined. The legislation and
sentencing policies that determine imprisonment rates are not. Only
Hamburg and Paris report data. Thus it is not possible in this report
to examine the degree of comparability in practice.
Addicts in prison
Amsterdam: Addicts received into selected prisons during the year.




London: Notifications of addicts by prison medical officers.
Paris: Special survey of addicts in one prison.
Rome: Annual census of addicts in two prisons on one day.
Stockholm: Annual census of addicts in prison on one day; monitoring
throughout the year of new inmates with sentences over two
months (addicts, drug users, nonusers).
2. Availability, accessibility, rapidity
Although data on sentences of imprisonment are only provided by two
cities, court data should be available in the other cities. Some, for
example Stockholm, indicate that city data has to be specially
extracted from national data. Thus for some cities, data are not easily
or rapidly accessible.
Data on addicts in prison are available easily and routinely only in
Rome and Stockholm. In London, they have to be specially extracted from
national data. Only in Stockholm is information available rapidly. In
the other cities, the data are not routinely recorded, but are derived
from special surveys.
3. Reliability
It can be assumed that court data are reliable as measures of the
number of drug offenders sent to prison. Apart from Stockholm, data on
the number of addicts in prison are considered unreliable.
4. Validity
Neither data on sentences of imprisonment, nor the number of addicts in
prison, are regarded as valid measures of the prevalence of drug misuse
in the community. However, in Stockholm, the data do indicate changes
in the drugs used.
Although of limited use for monitoring prevalence, court data on
sentences would be useful for comparing sentencing policy. It would
also be interesting to compare drug offences as a proportion of all
offences in the cities. Data on addicts in prison would also be useful
as a basis for comparing the treatment of addicts in prison.
Recommendations
(a) It would be interesting if future work focussed on sentencing
and penal policy, and treatment and follow-up facilities,
rather than strictly epidemiological issues.
(b) The reliability of data on addicts in prison needs study.
(c) Data for cities on sentences for drug offences need to be more
easily accessible
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2.7 Seizures of illicit drugs
The number of seizures and the total amount seized are commonly used to
indicate the existence, and sometimes the dimensions, of a market in
illicit drugs. This in turn is taken to reflect the level of use.
1. Comparability of definitions
There is a reasonable degree of comparability in terms of the
categories of drugs reported (heroin, cocaine, amphetamines, cannabis
etc.) the units of measurement (grammes or Kilogrammes); and the time
periods concerned (per annum).
Amsterdam: Quantities seized by the police
Dublin: Number of seizures, and quantities seized, by national
police and customs.
Hamburg: Quantities seized by police and customs. The number; of
seizures is reflected in detected cases (see Arrests).
London: Number of seizures and quantities seized by police.
Paris: Quantities seized by the police.
Rome: Number and quantities seized by police and customs.
Stockholm: Number of seizures by the police.
2. Availability, accessibility and rapidity
Data are available from the police for all cities except Dublin, where
information comes jointly from police and customs officials. Only in
Dublin, Hamburg, London and Rome are data provided for both the number
of seizures and the quantities seized. Further, it appears that in some
cities (for example London and Paris) the data are not routinely
available and that access depends either oh personal contact with the
police, or a formal process of requesting information. Despite this', in
all cities except Dublin, data are available relatively rapidly (within
six months).
3. Reliability
In principle, there should be a high level of reliability in terms of
accurately recording what is seized. In practice, this is unknown since
errors can arise where two or more authorities are involved (eg double-
counting; the same seizure) or where data are collated through more than




The validity of seizures as an indicator of the availability of illicit
drugs varies between cities and is affected by several considerations,
in particular (a) whether the data reflect the activities of
enforcement agencies rather than the state of the illicit market, and
(b) whether the data used refer to quantities seized or to the number
of seizures.
The total quantities seized are sometimes taken as an indicator of
illicit supply. However,it is not possible to know, by just looking at
the total quantities seized, whether the police have become more or
less effective (or lucky), or whether the market really has changed.
Thus one exceptional seizure can seriously distort the data for a given
year. Repeated seizures of large quantities may indicate that a 
substantial market exists, but variations in the total amount cannot be
assumed to be directly proportional to the size of the market.
It is also necessary to exclude seizures that are 'in transit' for
another destination. Relevant intelligence may be known to some
enforcement agencies, but it is not routinely available for
interpreting the significance of the data. This is especially relevant
.to major cities, which may be transit points for other parts of the
country as well as for other states. Perhaps the validity of the
amounts seized should be examined as an indicator at a national rather
than at a city level.
If the quantities seized are taken in conjunction with other
information, then it becomes more possible to examine their validity as
an indicator. For example, if the amounts seized increase markedly yet
prices are unchanged or falling, and purity is rising, then it is more
likely that the data indicate an expanding supply rather than more
effective interception. If other indicators point in the same
direction, then this interpretation is further confirmed. Information
on police priorities and resources allocated to,drugs is also needed.
The only cities where it is possible to set quantities seized against
prices are Amsterdam, Hamburg and London. In Amsterdam, increases in
the quantities of heroin seized coincide with falling prices (and rises
in the number of people arrested). A similar pattern is found in London,
where it is concluded that large changes are a valid indicator,
especially regarding heroin. On the other hand, in Hamburg it is
suggested that quantities seized are not necessarily a valid indicator,
especially regarding cocaine. In Sweden as a whole, it is suggested
that an increase in the quantities seized was correlated with increased
enforcement rather than an increase in use.
At the 'user' level, the quantities seized are less significant than
the number of individual seizures. In Hamburg, London Paris and
possibly Dublin, the number of seizures of user amounts are considered
a rough indicator of availability. However, data that routinely
distinguish user quantities are not routinely available.
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Substantial changes in the number of seizures, especially at street
level, may be an indicator of availability. The significance of the
quantities seized is more questionable, especially at a city level.
However, seizure data become more useful when taken in conjunction with
other market indicators and with information on enforcement policy and
resources.
(a) Data on the numbers of seizures and on the quantities seized
should be routinely reported.
(b) Seizures of 'user' quantities should be distinguished, as
should exceptionally large seizures.
(c) In the case of large seizures, it should be indicated whether
they were destined for the domestic market or not (if known).
(d) Information on the level of enforcement resources .and on
signficant changes in policy is necessary for interpreting the
data.
(e) The system(s) through which seizure data are collected,
collated and reported need further examination if they are to
be of greater epidemiological value.
2.8 Price/purity of illicit drugs
Drug price and purity are sometimes used to indicate the availability
of illicit drugs. A fall in price may indicate increased supply,
especially if the purity is rising.
1. Comparability of definitions.
The data on prices presented in the Appendix (Table IX) refer to a 
price range per gramme at street level {except for cannabis, which is
sold in ounces in Dublin and London).' Some information on 'dealer'
quantities is also available in London. Purity data, where available,
also refer to street quantities. In Hamburg and London, the purity of
small amounts (less than one gramme) are recorded separately.
2. Availability, accessibility, rapidity
Some data on prices are available in all cities except Stockholm. They
will be available in the future in Stockholm. Apart from Paris, the
data are recorded more or less routinely by the narcotics police. In
Paris, and additionally in London, data are derived from ethnographic
studies and from informal sources in touch with illicit drug users.
Only Dublin, Hamburg and London report purity data (from police
sources).
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The data are available to the police easily and rapidly. As with other
law enforcement indicators, the data, and the information needed to
interpret them, are not always so accessible to others.
3. Reliability
Reliability varies between cities. The data on prices are thought to be
a reasonable guide in Hamburg, London and Paris. In the other cities,
the reliability is unknown.
One issue that affects reliability is whether prices refer to the money
paid for a quantity that is sold as a gramme (or fraction of a gramme),
or whether they refer to an estimate of the 'true' price per gramme
when drugs are sola in small packets of unspecified weight. In the
latter case, the price per gramme is likely to be much higher than the
money paid when a user purchases a "gramme". This, seems to be the case
in Dublin, where one gramme is usually divided into 30 packets which
sell at €10 each.
Another issue is how the information on prices is obtained. Experienced
narcotics police who are knowlegable on how the illicit market works,
are likely to provide reliable information. Interviews with arrested
users by inexperienced police officers can produce misleading
information on prices.
Prices reported by the police may also be affected by other pressures.
For example, a wish to emphasise the significance of seizures or of
drug-related crime can lead to inflated figures. Conversely, a wish to
stress the problem of increasing availability can lead to selection of
the lowest prices.
In both London and Paris, the value is stressed of information on
prices obtained from ethnographic studies and informed sources close to
the drug scene. The reliability of such data can be high if the persons
concerned are themselves experienced and reliable.
Data on purity obtained by forensic analysis are assumed- to be
reliable.
4. Validity
Data on prices are considered to be a valid and sensitive indicator of
trends in availability in Hamburg and London, and potentially in Paris.
Thus in London the price of heroin fell sharply after 1978 (and
continued to fall until 1984). Subsequently, over the early 1980 s, all
the other major heroin indicators increased. It is hard to draw
conclusions about the other cities (apart from Hamburg) since this
indicator has not been closely examined.
Conclusions
When taken with other information, price/purity can be a sensitive
indicator of the state of the illicit market, in some cities at least.




(a) Both the price and the purity of illicit drugs should be
routinely recorded.
(b) The data should distinguish the price and purity of small
amounts (one gramme or less). Ideally, they should also
distinguish the price/purity of large quantities (over 1 kg.)
(c) Estimates of the "true" price per gramme based on very small
units of unspecified weight should be separated from data on
prices paid for a gramme or fraction of a gramme.
(d) Data on prices should be obtained from other reliable sources
as well as from the police.
2.9 Survey data
Survey data have not been a focus of this study. This was partly so as
not to duplicate the work of the school survey subgroup, and partly for
methodological reasons in relation to the focus on heavy, problem use.
Population or school surveys are useful for assessing . the extent of
more common drug use (alcohol, tobacco, cannabis, medicines etc). They
are less useful for rarer or more 'deviant' use since (a) large samples
are required, (b) such use may be more likely to be concealed, and (c)
random samples are particularly likely to miss truants from school, or
important groups living in 'marginal' social settings. Surveys of
conscripts, especially when supported by urine analysis, can provide
prevalence data on males in a limited age range.
Intensive case-finding studies are a valuable tool, albeit expensive.
They are useful for establishing a baseline from which to (a) monitor
subsequent trends, and (b) validate the various indirect indicators.
Ethnographic studies of drug users can be extremely valuable for
providing 'hard to get' data on the human dimensions of drug misuse,
2.10 Other indicators
Nonfatal drug-related emergencies seen in casualty departments have not
been considered in detail. This is because routine data were available
only in Amsterdam (on addicts taken to hospital by ambulance). In other
cities, data are not available, though surveys have been conducted in
Dublin and London.
Very few data are available concerning AIDS and drug misuse. In several
cities, research is under way or planned. Other indicators used include
injection marks amongst arrestees (Stockholm).
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3. AN INTEGRATED FRAMEWORK? POSSIBILITIES AND LIMITATIONS
Any attempt to develop a nore integrated and comparable framework for
monitoring drug misuse raises the central question of "How can
integration of information from diverse sources best be achieved?'*.
Section 3.1 describes a conceptual framework for examining indicators
with regard to this question. Section 3.2 looks at some o£ the methods
for combining indicators within a city, and section 3.3 at the levels
at which comparisons can be drawn between cities. Section 3.4 discusses
the administrative structures that are needed for integrating
information within a city, and section 3.5 takes! up this issue at a 
European level.
3.1 Conceptual framework for indicators
The starting point for a conceptual framework is provided in Figure 1.
In Figure 1, "Indicators" refers to data that are available from
reporting systems or routine statistics. "Known drug takers" refers to
people with drug problems seen by one or more agencies. The "known"
population may often be larger than is suggested by the indicator data,
since it is unlikely that reporting systems receive information on all
drug takers who come into contact with agencies. The "drug using
population" refers to all those who use drugs in the time period
concerned. This includes people with drug problems who have no contact
with agencies (hidden drug problems), as well as those who are known to
agencies. It also includes the larger number of people who use drugs in
an occasional, 'recreational' or less risky fashion. Clearly the
boundary between them and 'problematic users' is blurred. The figure
also indicates that, with the exception of death, the status of
individuals can vary over time.
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This conceptual framework is not intended as a rigid 'iceberg' model.
The visible portions of any indicator are not fixed and may vary for
reasons other than changes in drug use (eg changes in reporting or in
agency policies). Thus it cannot simply be assumed that changes in the
'visible' indicator are directly proportional to changes in drug
misuse. Part of the task of the expert group has been to examine the
validity of each indicator in regard to the total drug situation.
The rationales for using this broad framework are as follows.
(a) It emphasises that the data available at an overall city (or
national) level are the result of a filtering process:- not all
drug users come into contact with agencies; of those who do,
not all go to the same agencies; not all of those who contact
an agency are recognised as drug users; and only some of those
who are recognised as drug users are actually recorded or
reported in the final statistics.
(b) It emphasises that different indicators are selective, that is
to say they reflect the phenomenon of drug, misuse from
different positions.
(c) At the same time, the framework suggests that there is some
overlap between different indicators.Thus an important question
. is the way in which different indicators are (i) related to
each other and (ii) collectively related to- the drug situation.
This framework has three important implications.
(a) A range of different indicators are required. Moreover, both
statistical data and qualitative information are needed if the
significance of the data is to be elicited, and it is important
to include sources that are as close as possible to the drug
using population (that is to say, data which has passed through
less filtering).
(b) The different indicators roust be analysed and interpreted
together as a package, rather than separately. This in turn
requires a centre that can facilitate the use of consistent
protocols for collecting data, and then collate and integrate
the information obtained from different sources.
(c) Since the validity of each indicator as a direct measure of
drug misuse cannot be assumed, and may vary over time, it is
essential to carry out independent evaluations of the
indicators from time to time.
The next section examines various methods for combining information
within a city.
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3-2 Scientific aspects of integrating indicators within a city
Methods for combining information from different sources and different
indicators include:
multi-agency monitoring (registers etc.);
concomitant indicator analysis;
statistical projections from indicators;
Methods which are valuable for placing the statistical data in a wider
context and for evaluating the indicators include casefinding studies,
ethnographic studies, and school or population surveys.
The different ways of tying together information from different sources
are described in more detail below.
Multi-agency monitoring
Amsterdam, Hamburg, London and Rome have some form of coordinated
multi-agency data gathering. Some examples illustrate the value of this
approach.
In Amsterdam, the methadone registration system covers a wide range of
treatment settings, including addicts in police stations, prisons etc.
This makes it possible to avoid the double-counting of individuals
that, for example, is reported to have resulted in an overestimation of
the number of addicts attending treatment centres in Rome. The same
system makes it possible to monitor accurately the number of new cases
(first treatment demand) who are seen by almost any (methadone)
facility in the city. As well as providing a more accurate picture of
trends in opiate addiction, this indicates which sort of facility
addicts are most likely to approach first. It also shows, for example,
that half of arrested addicts have never been notified " as receiving
methadone. The system thus provides a valuable empirical basis for
planning services. A disadvantage of the system is that since it is
monitors the supply of methadone, it is unlikely to provide information
on other types of drug misuse.
In the UK, notification data were valuable in, for example, indicating
the increasing (but unplanned) involvement of GPs in the treatment of
addicts, and in showing changes in the age distribution of addicts
notified for the first time. A disadvantage is that the more detailed
(and more useful) data are only available nationally.
In Hamburg, studies based on the cumulative register of injecting
opiate addicts illustrate how different indicators can be used to
evaluate each other. Thus a retrospective study of addict deaths showed
no correlation between length of (known) addiction and the likelihood
of dying in any given year. This in turn suggested that drug-related
deaths were not an indicator of the incidence of new addicts.
Conversely, a study of drug-related deaths identified through screening
death records, showed that 80 percent of addicts who died were already
known. This suggested that the register was relatively comprehensive.
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Of particular interest is a long term study of opiate addicts notified
in the early to mid 1970 s which suggested that although 20% had died
by the mid 1980 s, 50% had 'matured out' of their addiction.
Thus, depending on the agencies included, multi-agency monitoring can
provide information on trends in 'known' prevalence and incidence,
changes in the profiles of users, overlaps between different agencies
and patterns of service utilisation. Apart from monitoring trends, such
a database is of enormous value as a starting point for more thorough
epidemiological evaluation of questions such as the long term
consequences of drug misuse.
Concomitant indicator analysis
An example of this approach was given earlier when discussing the
validity of seizures as an indicator of supply (2.8). It was suggested
that when seizures are examined along with price, then they are more
valid than when taken alone. This principle can be applied more
generally to include a wider range of indicators. Examples are provided
in the reports for Dublin, Hamburg and London.
Two general points emerge from the city reports. Firstly, many
indicators show short-term fluctuations. Variations from one year to
the next cannot be taken as a reliable sign of change. Consistent
trends over several years are much more significant. Secondly, the
significance of trends observed in a package of indicators must still
be interpreted in terms of independent, often qualitative information
about the agencies and about the drug scene itself.
Statistical projections from indicators
A number of statistical techniques are available that allow projections
from existing indicators or data sets to the 'hidden' population of
drug misusers. These include capture-recapture, nomination methods,
small area synthetic estimates, and so on.
The capture-recapture technique has been applied in London and
Stockholm. It is based on the overlap o£ cases recorded by two or more
different sorts of agency or indicator. It operates on the principle
that the smaller the overlap, the larger is the total number of
addicts. There are a variety of statistical applications of this
principle that allow total prevalence and incidence to be estimated.
Another technique used in London was nomination, which aims to
ascertain, through interviews with addicts, what proportion of their
addict friends have, or have not attended specified agencies. If a 
sufficiently broad sample are interviewed, it is possible to arrive at
an approximate ratio of the number attending agencies to the 'hidden' 
population. If the numbers at the agency are known, it is possible to
estimate total prevalence.
Although these and other, more sophisticated statistical techniques
allow projections to be made beyond existing indicators, they all
depend on the foundation of a good database.
3.3 Levels of comparison between cities
A review of the reports provided by the experts suggests the following
comments on which aspects of the situations in the cities can, or
cannot, be meaningfully compared at present.
1. ?§§2riE5i:Y§ comparison
As is shown in Section One of this report, the value of careful
descriptive comparisons should not be underestimated.
2- Prevalence of drug misuse
At present, comparison between cities regarding the level of drug
misuse is only feasible- on a crude and speculative basis. Given the
uncertainties of prevalence estimation, even in a single city, progress
in this area is likely to be slow. The following examples illustrate
the lack of direct and equivalent estimates.
Amsterdam (total population 676,500)
6,657 opiate addicts were registered by the CMR at some point during
1985. Thus 'registered' prevalence (over 12 months) was 22.5 per 1,000
population aged 15-39. The total number of opiate addicts in Amsterdam
in that year is not known, though it would have been greater than the
registered figure. However, it is likely that a substantial proportion
of addicts were registered at some point, since the CMR covers a large
range of methadone dispensing facilities that are widely spread and
easily accessible. A high proportion of addict visitors/nonresidents
would overstate prevalence amongst Amsterdam residents.
Greater Dublin (total population 915,000) \ 
798 opiate addicts treated at the Dublin treatment centre during 1985.
Thus 'treated' prevalence (over 12 months) was 2.2 per 1,000 population
aged 15-39. This figure excludes addicts treated by GPs, hospitals and
in prison, and includes a few who lived outside Dublin. The total
number of opiate addicts is not known, but one estimate suggests that
in 1985 there may have been about 1,700 opiate misusers in Dublin. This
would imply a 'true' prevalence rate of about 4.5 per 1,000 population
aged 15-39.
Hamburg (total population 1,694,000)
1,764 injecting opiate addicts were known to central register by
December 1985. Thus 'known' prevalence rate was 3 per 1,000 population
aged 15-39. Cases were largely identified through the legal system
(police and courts). The number of addicts treated in a year is about
200, giving a 'treated' prevalence (over 12 months) of 0.1 per 1,000
population. The total number of addicts has not been assessed
precisely, but it is thought that the majority are 'known'.
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Greater London (total population 6,609,000)
5,637 addicts (mostly opiates) were notified to the Home Office during
1984. Thus 'notified' prevalence (over 12 months) was 2.0 per 1,000
population aged 15-39. The 1985 figure will be somewhat higher. The
total number of opiate addicts in London is not known, but it has been
suggested that perhaps 25-30,000 people used opiates on a daily basis
at some stage during 1985. This would imply a 'true' period prevalence
rate for 1985 of about 8 to 10 per 1,000 population aged 15-39.
Paris (total population about 6,000,000)
There are no prevalence figures for 'treated' or 'known' addicts.
Rome (total population 3,696,000)
2,168 addicts under treatment in public health facilities in 1985. Thus
'treated' prevalence was 1.6 per 1,000 population aged 15-39. Surveys,
based on urine anlysis, of young men at first interview for military
conscription suggested a prevalence rate for Rome (1982) of 14.1
regular opiate users per 1,000 males aged 17-25 (equivalent to 4,200
male opiate users in that age range). A tentative projection, taking
account of females and users aged over 25, might give a figure of
around 10,000 regular opiate users. If reasonable, this would imply a 
prevalence rate of about 7 per 1,000 population aged 15-39.
Stockholm County (total population 1,545,000)
A case-finding study in 1984 suggested that there were about 3,000
intravenous users of amphetamines or heroin in Stockholm County, giving
a prevalence rate of about 5 per 1,000 population aged 15-39. Since the
study included corrections for errors and unreported cases, this
represents an estimate of the 'true' prevalence (of use by injection).
The prevalence rates outlined above cannot be directly compared since
they are based on different sources and different methods of estimating
prevalence rates.
3. Rates of change in drug misuse
It is more feasible to make broad comparisons of relative trends in
drug misuse on the basis of existing indicators, but there are
substantial areas of uncertainty. However, this is an area where the
group believe progress can be made. The broad trends in drug misuse are
not reviewed here, since they were contained in the first volume of
this report.
4. Characteristics of drug misusers
These too can be compared in a rough and ready fashion, but only on
fairly basic items such as age and sex, and in most cases only for
selected subgroups of drug misusers. Progress in this area would be
useful and should be feasible.
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5. Patterns of agency contact
It is possible to compare most cities in terms of which agencies are
most commonly in contact with drug misusers. The point is not to
compare numbers, but the profiles of drug misuse as they are presented
through the indicators available in the respective cities. The
assumption here is that since the indicators are based on data from
agencies concerning their contact with drug misusers, the profile of
indicators reflects the pattern of responses in the cities concerned.
This provides an empirical basis from which to start to compare the
operation of policies in the cities. Whether this is a fair assumption
depends in turn on the extent to which the data actually cover the main
agencies that see drug misusers.
A preliminary example of this sort of comparison is provided in Figure
2. For each city, the columns on the left refer to treatment and law
enforcement indicators; the columns on the right to hepatitis and
deaths (the scale for these is ten times greater than for the
indicators on the right). The cross-hatched areas refer to opiates only
(or in the case of Stockholm, to addicts).
It can be seen that in Hamburg, the register of addicts (mostly
identified through the police or the courts) is the primary
indicator and that treatment data is relatively unimportant. Similarly,
in Paris and Stockholm, the lack of treatment information leaves police
data (and deaths or hepatitis) the primary indicator. By contrast, in
Amsterdam, Dublin, London and Pome, the most prominent indicators are
derived from treatment systems.
In Amsterdam, Rome, and perhaps Paris, the number of arrests for opiate
offences under drug legislation account for a majority of all recorded
offences, whereas in Dublin, Hamburg, London and probably Stockholm,
cannabis accounts for most arrests.
This example is oversimplistic and contains many shortcomings, not
least because of the difficulties described earlier regarding
definitions and the quality of the data. Furthermore, the profiles
reflect the availability of data as well as the actual pattern of
agency contact. For example, a London study showed that many addicts
are seen by probation officers (for nondrug offences), suggesting that
a larger number of addicts pass through the legal process than are
reflected in arrest statistics. The numbers seen by voluntary agencies
aiso correct the picture suggested in the London data, that treatment
is only carried out by clinics and GPs. However, this sort of
comparison points to more interesting questions than mere comparison of
numbers. It should be feasible and valuable to develop this approach in




6. Social and economic costs of drug related problems
It is not yet possible to make quantified comparisons in terms of
broad problems such as illegal supply, drug-related crime, or the
social/economic costs of drug misuse, though the city reports allow for
some comparison at a descriptive level. It is possible, however,
to illustrate how comparisons on one aspect of the illicit market
might be made, the price of illicit drugs. The data currently
available are limited by the problems of reliability described earlier
and should not be assumed to be comparable. However, they suggest that
there may be large differences between cities, and that the pattern of
differences may vary for different drugs.
Street prices of illicit drugs per gramme, in ECUS, 1985
K
Heroin Cocaine Hashish
Amsterdam 30 - 60 5 0 - 7 0 1.9-3.0
Dublin 260 - 400 260 - 340 3.7 - 4.8
Hamburg 160 - 190 120 9.2
London 120 - 140 70 - 90 3.6-5.8
Paris 70-170 6 0 - 9 0 3.6-8.7
Rome 100 - 400
7. Causes of drug misuse and impact of interventions
This report does not compare either the relative importance of
different aetiological factors, or the impact of different policies and
interventions. This is a key area to which epidemiology can make a 
major contribution. The issues are complex and would probably require a 
special study. A necessary foundation for any attempt to consider these
questions, is a comparable and continuous information base concerning
the trends and characteristics of drug misuse in different cities or
countries.
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3.4 Administrative monitoring structures
A major problem encountered by all participants in this study was the
time and trouble that was required to collate information from
different sources that were not already covered by a city-based routine
reporting system. In some cases, the information requested had to be
specially extracted from existing routine sources. In other cases, it
took months before even the most basic data were supplied. Often,
information was obtained only because of personal contacts within
particular authorities. If the contact person changed job, then the
information became more difficult to get. where data came from
different agencies, it was usually difficult to compare, even between
similar agencies with similar clients.
Thus a fundamental requirement of improved monitoring within the cities
is an administrative structure for coordinating the collection and
collation of information.
The collection of consistent, standard information from different
sources, at whatever level, requires the following.
(1) A centre, with sufficient resources, to routinely collate
information, both statistical data and the more qualitative
information and intelligence1 needed to interpret the data.
(2) Standard guidelines and protocols for collecting and reporting
data to the collating centre.
(3) A consistent format for producing reports of the results and a 
mechanism for disseminating the information to planners and
services on a regular basis.
There are elements of such centres in some of the cities. Thus in
Amsterdam, the CMR collects data relating to methadone provision.
However other data (from hospitals, drug free agencies and especially
law enforcement) are not covered.
In Hamburg, the reverse is found. The monitoring system is administered
by the drug commissioner, in collaboration with the narcotics division
of the police. Whilst collection of data on addicts coming to the
attention of the police and on other aspects of law enforcement are
coordinated, a similarly comprehensive collection of treatment data is
somewhat difficult.
In Rome, monitoring is part of a three tier system coordinated
nationally by the Ministry of the Interior. This collates basic
(aggregated) data from local health units. It also collates data on
deaths and seizures. The regional health authorities collate more
detailed data from local health units and produce six monthly reports.
Both the national and the regional reports provide data that refer to
Rome- However, there is no structure in Rome itself for relating those
data to other local information about the situation in the city.
In Stockholm, the Swedish Council for Information on Alcohol and Other
Drugs is developing a regional reporting system to coordinate the
collection of information from key persons together with the various
statistics and surveys. It is not intended to develop a register of
known users, for ethical reasons, and because it is not considered
necessary.
In the other cities (Dublin, London and Paris), there are no structures
for bringing data from different indicators together with other
relevant information. This poses particular problems in London and
Paris, perhaps because of their size and the number and diversity of
agencies.
Possible models
It was suggested in the original proposal, "Overview of a multi-city
Study of drug misuse" (1), that the outcome of this
study should serve as a model for future developments. However, it is
clear that even between just seven cities, there are major differences
in terms of what sort of administrative monitoring systems are
feasible. With this in mind, it is not possible to present a single
blueprint. The important element of any system is that data from all
the different indicators are routinely brought together in one place.
The actual form of any centre will depend on the local context.
Similarly, whether the centre is associated with the public health
service, the criminal justice system, the local government structure,
an interdepartmental arrangement or an independent institution will
depend on the historical and political traditions in each city. If the
aim is to collate information on medical, legal and social aspects of
drug misuse, then it may be preferable that any centre is not too
closely identified with the interests of one particular section.
The two basic models that have been put forward are:
a case reporting system to which different agencies notify
individuals;
an 'intelligence' collating forum which brings together
statistical data and other information from all sources.
Examples of case reporting systems have been described above. From an
epidemiological point of view, they can be most valuable. However, as
indicated above, they all serve functions for particular administrative
purposes (health, enforcement etc), and therefore do not cover areas
that fall outside those purposes.
From a purely epidemiological point of view, the 'ideal' is a 
comprehensive register of all drug misusers known to all agencies
(treatment, police, social services etc.). However, this is not
proposed in this report. In most cities, it would be impossible, both
for reasons of confidentiality, and for reasons of cost, lack of
cooperation from agencies, and the fact that it would deter drug users
from seeking help.
(1) Pompidou Group meeting of epidemiology experts in drug problems,
Paris, 13-15 June 1984
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An alternative form of reporting system is one in which anonymity is
preserved. Thus it is not individuals who are reported, but events
(demands for treatment etc.). This avoids problems of confidentiality,
but not the size of the administrative task, nor the cost. In addition,
it is not possible to study the overlap between agencies nor to follow
up cohorts of drug users through the various treatment/control
services. In some cities, the problem of double-counting is minimised
by using anonymous identifiers, such as date of birth, sex and
combination of initials, but this too is not always acceptable.
It is in any case unlikely that comprehensive case reporting, whether
totally anonymous or not, would work across all medical, social and
enforcement services. This is partly because of the sheer coaplexity of
administrating such a system, and partly because different services and
administrations require different information for different purposes.
It would be counter-productive to attempt to develop a system that was
all things to all people. There are also important sorts of information
which do not refer to individuals at all (seizures, price and purity,
ethnographic studies and other qualitative 'intelligence').
Thus, in addition to the various separate reporting systems (where they
exist)• there remains a need for an 'intelligence' collating centre or
forum. A schematic outline of such a monitoring system is given below,
followed by an account of what it might involve.
Schematic repsentation of monitoring_system
Sources Input
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It would also be important that continuing attempts were made to
improve the quality of the individual indicators as recommended in
Chapter 2, and that the information from the monitoring system were
supplemented by epidemiological research (ethnographic studies, surveys,
follow-up studies etc.) The formulation of such a monitoring system
would involve a development phase before it became functional.
Development phase
(1) Review the situation in the city and list a wide range of
sources of information, with particular attention to key people
who work in relevant agencies and administrative structures or
who are well informed about the drug scene.
 K 
(2) Define a set of ideal indicators, together with core data of
particular epidemiological significance. The indicators covered
in this report should all be included at this stage.
The multi-city study provides some of the groundwork for this in the
cities concerned.
(3) Negotiate with the agencies and administrations whether, how
and in what form data can be reported to the centre rapidly and
on a routine basis that is mutually acceptable. This is time
consuming.
(4) Develop protocols and guidelines for data reporting.
(5) Set up a database. Whether this is associated with a case-
reporting system (as in Amsterdam) or just stores statistical
data collected by other structures (as is planned in Stockholm)
will depend on local circumstances.
(6) Pilot procedures and modify accordingly.
Functional phase
(7) Collate data on a routine basis. This requires regular contact
with the various agencies and administrations.
(8) Keep in regular contact with key persons and record significant
'intelligence' information, research reports etc.
(8) Analyse data and write brief reports (every 3 or 6. months?). ' 
(9) Organise a meeting (every 6 months?) of all key persons to
exchange information, report local events and discuss the
significance of the various indicators. ! . 
(10} Disseminate reports (every 5 months?) on recent developments to
all parties involved.
(11) Provide information in response to- particular requests* from
policy makers, agencies etc. 
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The resource implications of such a centre would depend on its terms of
reference and on the degree to which a structure already exists.
However, any centre requires (a) full-time core staff, with
epidemiological expertise, administrative support and adequate computer
facilities, and (b) sufficient institutional support at a senior level
in the structures concerned (health, police etc) to ensure that the
centrs has the authority to operate without the need to continually
negotiate access to data.
Comment on national information systems
National data gathering is strictly outside the objectives of this study.
However all countries|are concerned to form a nationwide picture of
drug misuse, whilst at the same time having information on variations
within the country. A short comment is thus in order concerning the
balance between national and local monitoring.
All countries have national indicators, but it is not clear whether
they provide an accurate picture. An example of a more extensive
national monitoring system is found in the United States. Until
recently, it consisted of the following components.
DAWN (Drug Abuse Warning Network) - monitors drug-related
incidents in emergency rooms and drug-related deaths.
CODAP (Client Oriented Drug Abuse Profile)- monitors admissions
and discharges from federally funded treatment programmes)
Law enforcement indicators (arrests, seizures, price/purity)
Hepatitis B monitoring
National Household Survey (repeated)
National High School Survey (repeated)
The National Institute on Drug Abuse is the centre responsible for
developing protocols for data reporting, and for collating and
analysing data from different parts of the country. It also conducts
and supports epidemiological reasearch on particular issues. The
results are made available through a regular series of publications.
The advantage of such a system is that it is standardised nationally
for a range of indicators, whilst at the same time it can provide
comparable information about specific areas within the country.
The disadvantages for many European countries are that this sort of
comprehensive data system would be expensive, difficult to set up, and
cumbersome to administrate. This is partly because of the policies of
decentralisation that are found in some countries. Furthermore, and
this has also been a criticism of the US system, it is relatively
insensitive to local circumstances, unless there is additional locally-
relevant information available. This can result in poor quality data
unless local agencies are motivated to participate.
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In this context, the model from the U.S. that is of particular interest
is the Community Epidemiology Work Group (ex Community Correspondents
Group). This consists of experts from major cities who meet every six
months to report local indicators in standard format, and to discuss
the similarities and differences between different parts of the
country. An executive summary provides a national picture with regional
variations. These meetings also provide a forum for presenting reports
on particular issues of current epidemiological concern (for example
cocaine or AIDS).
In European countries, a national network of local centres, such as
those recommended for the cities in this report, could fulfil the same
function. Some central administrative support would be necessary, but
not on the scale required by national data gathering ' systems. The
development of regional reporting systems in Sweden appears to be a 
move in this direction. The balance between national and local
monitoring would, of course, depend on the size and political structure
of the various countries.
3.5 European CO-OPERATION and comparability 
Improved comparability and integration of data in Europe requires that
there is an appropriate political/administrative structure for ensuring
that progress is made. As with the requirements for monitoring within a 
city or country, any attempt to monitor and compare the situation
across Europe needs: 
(a) agreed guidelines on data gathering, and
(b) a continuing mechanism or forum for receiving, syhthesising,
interpreting and disseminating information.
If the reservations expressed earlier about large, national monitoring
systems are valid, then the possibilities of developing a pan-European
monitoring system on the scale of the NIDA American model are even more
distant, not least because of substantial differences in the whole
organisation and function of the various societies' institutions.'
An alternative model for monitoring at a European level is the
Community Correspondents Group described earlier. There are two ways of
arranging such a model
(1) The Pompidou Group institutionalises the epidemiological
working party as the forum in which the experts meet every six
months to (a) present an update, in a standard format, on
national trends, and (b) produce, with the other experts, a 
brief report that summarises the major trends and differences
across Europe.
Such a forum would also facilitate the continuing exchange of
information on epidemiological methods and results of new studies.
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(2) Set up a European epidemiological centre to:
liaise with national centres;
define, in consultation with national centres, basic
protocols for reporting data (as comparable as possible);
synthesise the information on a regular basis;
hold regular meetings to discuss the significance of the
information and to identify future needs in this field,
disseminate
 ( briefings on the European situation to
national centres and other relevant national/European
bodies.
This, effectively, is similar to the model proposed for monitoring in a 
city, but adapted to a European context. Such a centre could be under
the umbrella of the Pompidou Group or it could be based elsewhere. It
would, in any event, need full-time staffing.
Any move towards European coordination and comparability must take
place with full consultation with other European bodies, notably the




(1) It is important to improve the quality and comparability of
data gathering because:
cities need information for planning and evaluation;
concerted action needs information on patterns of drug
misuse across Europe;
individual countries can better benefit from the
experience of others.
(2) This study has focused on more serious, problematic drug
misuse. It thus complements the pilot study of drug use being
carried out in the school survey subgroup.
(3) The expert group considers that it is possible to make
meaningful comparisons and to improve the quality and value of
those comparisons, as long as progress is made with regard to:
the comparability of the criteria;
the routine integration of data from different sources;
the continuing exchange of information concerning the
wider contexts in which data are collected.
Indicators
(4) It is not possible to assume a direct correlation between an
indicator and the prevalence of drug misuse. The indicators
examined in this study are indirect and may be influenced by
other factors such as changes in reporting or in the policies
and activities of the agencies concerned. It is therefore vital
to:
use a package of different indicators and examine their
collective significance;
assess the empirical validity of indicators in terms of
other information on the extent of drug misuse (eg
independent research).
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(5) A number of indicators have been examined by the group. The
significance of the data and the levels at which they can be
compared varies, depending on the indicator concerned and on
which cities are considered. In general, there is considerable
room for improvement in terms of:
the consistency and comparability of the criteria;
the accessibility of the data and the rapidity with which
they can be obtained;
the quality of the data in terms of reliability and
validity.
Chapter 2 makes recommendations as to how individual indicators
might be improved.
(6) The two indicators that are considered of particular value in
most cities are:
the demand for treatment from medical and social
facilities, and in particular, first requests for
treatment by previously unknown drug misusers;
police arrests for offences involving illegal drugs
(7) Three other indicators that are important and that would, if
improved, add substantially to the range and quality of
epidemiological information are:
drug-related deaths;
illicit market indicators - drug seizures and price;
hepatitis
•i i 
(8) Data on hospital admissions and imprisonment are generally
considered to be of less epidemiological significance.
(9) In addition, several members of the expert group consider that
it is essential to complement data derived from the agency-
based indicators listed above with qualitative, first hand
information from ethnographic (anthropological) studies of drug




(10) The expert group have examined several levels at which
comparisons might be made between cities. In general, the
degree of direct comparability is low. However it is possible
to start to make rough comparisons between some cities at
the levels of:
description (see volume one of this report);
- certain trends in drug misuse;
profiles of drug misusers reflected in some indicators;
the relative significance of different indicators;
the prices of illicit drugs.
It is not feasible at present to compare directly the true
prevalence of drug misuse. However it is possible to compare




A major problem that was identified in most cities was the lack
of a structure for collecting and integrating data from very
different sources in a consistent and coherent fashion. In each
city there is an urgent need to improve and formalise the
channels for pulling together information on a centralised,
systematic and continuing basis.
Two basic models for monitoring systems have been considered. 
They are: 
case reporting systems in which different agencies notify
individuals to a central database (either by name or
anonymously);
an intelligence gathering centre which brings together
aggregated statistical data and other information from a 
wide range of source.
(13) Case reporting systems are useful both for monitoring trends
and for providing a sampling frame for more detailed studies.
However, they are expensive, cumbersome to administrate, and
limited by concerns over confidentiality. In particular, it is
neither feasible nor desirable to develop a single database
that records cases from health, social and legal agencies and
administrative structures.
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(14) In all cities, there is a need for a centre which brings
together, on a continuing and consistent basis:
aggregated data from the separate administrative reporting
systems (public health, police, courts, etc.);
data on the individual indicators;
information from key individuals, research centres etc.;
any other relevant intelligence on drug misuse.
An important function of such a centre would be to interpret
the collective significance of the information and produce
regular reports on the situation. The need for a centre is
discussed in section 3.4.
Future European epidemiological activities
V
(15) There is a need for a continuing forum in Europe which would:
collate and compare epidemiological information on trends
in drug misuse in different countries, and discuss their
significance;
exchange information on different methods;
facilitate the use of more comparable criteria in
indicators and monitoring systems centres in the various
countries. 
The model of the Community Epidemiology Work Group is put
forward as one way in which this could be done. The
epidemiology expert working party in the Pompidou Group could
fulfil this function. An alternative is to establish a 
European epidemiological centre.
(16) The work done on the multi-city study over the past three years
is a basis only, not a completed solution to the problems of
obtaining better and more comparable information on the nature
and extent of drug misuse. It is important that future work
builds on this study.
(17) Other recommendations for future activities from the expert
epidemiology working party as a whole are given in a separate
document. Any future activities should have regard




A P P E N D I X
REFERENCE DATA (*)
Introduction
This paper contains population figures for the seven cities and
data from eight indicators of drug misuse. The tables containing
indicator data appear in the same order as they are discussed in the
technical report on indicators of drug misuse. For each indicator the
data from the different cities are presented in the alphabetical order
of the cities.
i.
The figures were selected from tables in the individual city
reports or have been provided subsequently by the participating
experts, and are presented here according to a standardised format per
indicator, for the sake of ease of reference.
Ease of reference does not however constitute comparability of
data. Comparability of data is not only dependent upon the.
comparability of definitions used but also on the framework within
which particular sets of data have been collected. Specific care
should therefore be taken as to any direct comparison of the presented
data. It will be observed that where definitions differ the data
should not be considered separately from the overview and synthesis of
city reports (see Section 1 of the present publication) and the
technical report on indicators of drug misuse in the seven cities (to
which these data are appended).
The rates given are per 1,000 population aged 15-39 (except for
Paris, where the rates refer to the age group 15-34).
(*) compiled on the basis of a draft submitted by Ms A J de Roij-Motshagen





Population decrease: 12.22 (period 1975-83)
Age M F T % 
-15 48,213 46,518 94,731 14.0
15-19 21,836 21,700 43,536 6.4
20-29 69,975 69,311 139,286 20.6
30-39 59,828 53,244 113,072 16.7
40-49 36,650 33,761 70,411 10.4
50+ 90,297 125,191 215,488 31.9




Population increase: 12.7% (period: 1971-81)
Age M F T % 
-15 133,948 127,618 261,566 28.6
15-19 47,469 49,682 97,151 10.6
20-29 78,282 84,491 162,773 17.8
30-39 55,740 58,092 113,832 12.4
40-49 42,683 46,002 88,865 9.7
50+ 79,736 111,192 190,928 20.9




Population decrease: 8.9% (period: 1973-83)
'i
Age M F T % 
-15 107,682 104,307 211,989 12.5
15-19 62,207 60,007 122,214 7.2
20-29 121,755 116,384 238,139 14.1
30-39 119,228 106,764 225,992 13.3
40-49 199,738 122,999 322,737 19.0
50+ 219,607 353,629 573,236 33.8
Total 830,217 864,090 1,694,307 99.9




Population decrease: 7.0% (period: 1974-84)







































Population decrease: 5.5% (period: 1975-82)
Age * M F T X 































Population increase: 5.9% (period: 1971-81)
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II. First treatment demand
Amsterdam
Definition: Addicts registered for the first time by the Central
Methadone Registration System following provision of
methadone at any of a vide range of facilities
Method: Central collation per individual


























Definition: Drug users taken on for treatment for the first time by
Jervis Street, the city's main treatment centre
Method: Central collation per individual






























Definition: Drug users requesting aid from drug counselling centres
(who have not done so the previous year)
Few precise data on first requests are available at present.
Drug counselling centres report that on average 250 "new"
drug-dependent persons make a request for aid each year.
According to reports, from 1980 to 1984 1,117 persons sought aid
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London
Definition: Narcotic addicts notified for the first time to the
Home Office
Method: Central collation per individual


























Definition: Nev cases seen by individual treatment centres
No consistent data available. Data on first treatment demand are
published yearly separately by each care centre.
Rome
Definition: First application for treatment by drug users to public
health (PH) facilities and therapeutic communities (TC).
Method: Central collation per individual.
Year First contact (Rate) Re-contact (Rate)

















Definition: Drug users treated by therapeutic communities and other
social and medical facilities
No routine data on treatment available. In general it is
difficult to acquire very precise information on the total number of
drug users who receive care through the various treatment centres. No
distinguishing of new cases.
- 61 - Appendix
III. Hospital admissions/discharges
Amsterdam
Definitions: Primary and secondary discharge diagnoses at general
hospitals (A)
Primary admission diagnoses at psychiatric hospitals (B)
A.
ICD-code/year 1981 1982 1983
292 9 19 10
304 206 200 200
305,2-9 25 295 327
Total 240 514 537
(Rate) (0.8) (1.1) (1.1)
B.  
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Dublin
Definitions: Primary and secondary discharge diagnoses at general
hospitals (A)



























































Admission figures for drug addicts are reported only by the
detoxification unit (A). Other hospitals do not accept drug addicts
as patients, except in the case of emergency treatment for overdose.
Year 1980 1981 1982 1983 1984 1985
Number 147 182 206 199 202 185
(Rate) (0.3) (0.3) (0.4) (0.3) (0.3) (0.3)
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London
Definitions: Discharge diagnoses at general hospitals (A)
Admission diagnoses at psychiatric hospitals (B)
A.







































Data available only from a survey of cases seen by institutions
during the last quarter of each year.
Rome
No routine collation.
Hospital admissions of addicts refer almost entirely to
emergencies related to critical episodes.
Stockholm
Information on hospital admissions is not available on a routine
basis.
Statistics on discharges from psychiatric hospitals do include
cases of drug addiction (ICD 9 classification). Hovever, the time-lag
for these data is approximately five years.
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IV. Hepatitis
Amsterdam
Definition: Cases of hepatitis notified to the public health
authorities by general practitioners, by source of
infection
Source of infection
Total (Rate) Drug use Other
1983 113 (0.4) 19 94
1984 70 (0.2) 23 46
Dublin
Definition: Positive test for hepatitis B amongst addicts admitted


























Definition: Hepatitis cases reported by doctors to the city health
authority, by type
Year Number (Rate)* B non A non B 
1983 414 (0.7) 277 . 137
1984 407 (0.7) 269 138
1985 374 (0.6) 291 83
* The rates assume that all reported cases were found in the age
group 15-39 years. This assumption might not be justified.
. . . - - . . . 
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London
Definitions: Positive tests for hepatitis B reported to the central
public health laboratory by local laboratories, by source
of infection (A)









* Area - London and Thames Health Regions






































Not used as an indicator
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Rome
Definitions: Positive tests for hepatitis among patients admitted to
hospital for infectious disease, by type and by source
of infection (A)
Data are only available vith some years' time-lag..
Notifications of hepatitis cases to the public health
authority (B) , 
Only provisional data are available.
Voluntary reports of hepatitis cases to the Institute of
Health, by type (C)
Data from survey studies (D):
1. Viral hepatitis among addicts under treatment, by
type (N = 778);
2. Trends in hepatitis B and non-A non-B and addicts
involved treated in the main specialist hospital;
total number of cases in Rome.
Dl.
Year Number (Rate) Type
A B non A non B undetermined
1984 243 (0.2) 10 156 11 66
D2.
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Stockholm
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Drug-related deaths
Amsterdam
Definitions: Unnatural deaths of drug takers by overdose (A) and
deaths indirectly caused by drug misuse (drug-related
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Hamburg
Definition: Deaths by overdose of narcotic drugs (accidental or
suicide);
deaths of chronic drug takers by overdose of other drugs;
deaths indirectly caused by drug misuse (accidents under
the influence of illicit drugs and suicides of knovn
addicts);
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London
Definitions: Deaths by poisoning (ICD-9: 960-989) (A)


















** area: Inner London
Paris
Definition: Deaths by overdose of illicit drugs, recorded by the













* rate per 1,000 population, aged 15-34
71 - Appendix
Rome
Definition: Deaths by overdose of narcotics;
deaths in circumstances indicative of drug addiction;
drug-related deaths of persons irrespective of whether








































































Definition: Persons arrested by the police for offences against the
drug legislation (first stage of the procedure for
bringing charges for specific offences)
Only a minority are subsequently charged.
Tables A: Number of persons arrested; number of persons charged and
medically examined
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Dublin
Definition: Number of persons charged for a specific offence against
the drug legislation
Tables A: Total number of persons charged under the Misuse of Drugs
Act 1977 and 1984
B: Total number charged, by drug involved; other offences








































Definitions: Number of detected cases of offences against the drug
legislation
Number of persons suspected of specific offences against
the drug legislation
Tables A: Number of detected persons having committed offences against
drug legislation and number of offences ( = cases) against
drug legislation
B: Number of offences ( = cases) related to drug use by drug
type
A.






















































Definition: Number of arrests by the police for offences against the
drug legislation (first stage of the procedure for
bringing charges for specific offences)
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Paris
Definition: Number of police arrests for offences involving drug use
and trafficking
Year Number



























Definitions: Number of persons charged vith drug trafficking (A)




Reported (Rate) Charged (Rate)
1982 1,745 (1.3) 1,213 (0.9)
1983 2,164 (1.6) 1,130 (0.8)
1984 2,373 (1.7) 1,435 (1.1)










Definitions: Number of reported offences against the drug legislation
Number of persons suspected of offences against the drug
legislation
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VII. Imprisonment
Amsterdam
Definition: Addicts received into selected prisons during the year
No routine collection: no significant data available
Dublin
Definition: Persons identified as addicts in surveys by prison medical
services
No routine collection of data
Hamburg
definitions: Persons sentenced for offences against drug
legislation (A)
Number of imprisonments (B)
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London
















* rates are not available since the origial data are not broken down
by age
Paris
Only specific survey data available on addicts in prison
Rome
Definitions: Annual census of addicts in two prisons . 
Imprisonment after being convicted of drug trafficking
(B)
Data not suitable for epidemiological purposes
B.



















Definition: Addicts in prison on one day: point prevalence on
1 April each year.
Year Number (Rate) % of total prison population
1980 74 (0.1) 30
1983 110 (0.1) 40
1985 184 (0.3) 48
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VIII. Seizures of illicit drugs
Amsterdam
Definition: Quantities seized by the police (in kilogrammes, unless
otherwise stated in brackets)
Drug/Year 1981 1982 1983 1984 1985
Opioids
Opium 0.21 0.96 x 0.18 0.02
Morphine 5.89 0.45 x 0.09 x 
Heroin 29.63 46.50 51.00 70.00 175.00
Other (opioids) 4.16 5.00 7.00 0.50 0 
Other (opioids)
(tablets) 9,508 5,395 5,763 5,503 4,350
Stimulants
Cocaine 6.68 9.00 21.15 47.00 15.00
Amphetamines 24.20 11.60 45.00 0.38 125.00
Amphetamines
(tablets) 1,190 2,500 60,000 0 0 
Other (stimulants) 10.49 7.00 0 0 6.10
Other (stimulants)
(tablets) 80 37 20 0 200
Hallucinogens
Marijuana 2,216.00 2,200.00 200.00
Hashish 1,981.00* 869.00 1,775.00
Liquid hashish 0.40 1.95 0 
LSD (units) 4,389 48,535 2,752
x: insignificant amount
*: includes one case of 1,500 kg













Definitions: Quantities seized (in kilogrammes, unless otherwise stated
in brackets) (A) and number of seizures (B) by the






























Liquid hashish x 
LSD (tablets) 211
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Hamburg
Definitions: Quantities seized (in kilogrammes unless otherwise stated
in brackets) (A) and number of seizures (B) by police and
customs
A.
Drug/Year 1983 1984 1985
Opioids
Opium 11.34 1.69 1.11
Heroin 8.03 20.01 9.61
Stimulants
Cocaine 0.82 7.27 0.63
Amphetamines 0.02 0.01 2.07
Hallucinogens
Marijuana 326.72 28.13 5.45
Hashish 153.76 40.39 . 43.27
LSD (units) 396 60 922»
B.
Specified data not available at present
i .
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London
Definitions: Quantities seized (in kilogrammes) (A) and number of
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Rome
Definitions: Quantities seized (in kilogrammes) (A) and number of







































Stockholm City and County
Definitions: Quantities seized (in kilogrammes) (A) and number of
seizures (B) by police
A.










IX. Price/purity of illicit drugs
Amsterdam
Prices in ECUs per gramme
































Purity in %: not available
Dublin
Prices in ECUs per gramme (unless othervise stated)
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Hamburg
Prices in ECUs per gramme
























Prices in ECUs per gramme


























Prices in ECUs per gramme














Prices in ECUs per gramme





Heroin per gramme 5-10
Stockholm
.No systematic collation of data on prices and purity at present
These data will be available in the future.

